Ipragliflozin Uses, Dosage, Side Effects and more
Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2.
| Trade Name | Ipragliflozin |
| Generic | Ipragliflozin |
| Ipragliflozin Other Names | Ipragliflozin |
| Type | |
| Formula | C21H21FO5S |
| Weight | Average: 404.45 Monoisotopic: 404.109373113 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
